Ticker Scout
← tickerscout.ai

UnitedHealth Group Incorporated (UNH) Financials

CIK 0000731766 · NYSE · Latest period: Q2 FY2026 (ended 2026-06-30, 10-Q accession 0000731766-26-000197) · Annual report: FY2025 10-K (filed 2026-03-02, accession 0000731766-26-000062) · Next expected filing: 10-Q ~2026-10-27

PeriodQ2 FY2026

Published

UnitedHealth Group reported net earnings attributable to common shareholders of $5.48 billion for Q2 FY2026, the quarter ended June 30, 2026, up 61.0% from a year earlier, or $6.04 per diluted share against $3.74. Total revenues were $112.03 billion, up 0.4%, while earnings from operations were $7.99 billion, up 55.2%. UnitedHealth Group's medical care ratio was 86.7%, down 2.7 points from a year earlier, which the company attributed to favorable development of prior-period medical cost reserves, affordability and medical cost management initiatives, and pricing.

MetricAmountvs. year ago
Revenue$112,032,000,000up 0.4%
Net earnings$5,484,000,000up 61.0%
Diluted EPS$6.04up 61.5%
Earnings from operations$7,991,000,000up 55.2%
Medical care ratio86.7%down 2.7 points

Company details

NameUnitedhealth Group Inc
TickerUNH
CIK0000731766
ExchangeNYSE
StateMinnesota
IncorporationDelaware
SIC6324
OfficeFinance
IndustryHospital & Medical Service Plans
Latest period coveredQ2 FY2026, ended 2026-06-30, 10-Q, accession 0000731766-26-000197
Fiscal year end12/31 (MM/DD)
Next expected filing10-Q around 2026-10-27 (predicted)

Data files

  • Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included, plus a figure_sources block linking each figure the filing tags to the line that prints it.
  • 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
  • 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.

FAQ · UnitedHealth Q2 FY2026

How much did UnitedHealth Group earn in Q2 FY2026?

UnitedHealth Group reported net earnings attributable to common shareholders of $5.48 billion for Q2 FY2026, the quarter ended June 30, 2026. That is up 61.0% from $3.41 billion in the same quarter a year earlier.

What was UnitedHealth Group's diluted EPS in Q2 FY2026?

UnitedHealth Group reported diluted earnings per share of $6.04 for Q2 FY2026, the quarter ended June 30, 2026, against $3.74 in the same quarter a year earlier, up 61.5%.

What was UnitedHealth Group's revenue in Q2 FY2026?

UnitedHealth Group's total revenues were $112.03 billion for Q2 FY2026, up 0.4% from $111.62 billion a year earlier. On that revenue, UnitedHealth Group's earnings from operations were $7.99 billion, up 55.2% from $5.15 billion.

What was UnitedHealth Group's medical care ratio in Q2 FY2026?

UnitedHealth Group's medical care ratio, its medical costs as a share of premium revenue, was 86.7% for Q2 FY2026, down 2.7 points from 89.4% a year earlier. The company attributed the lower ratio to favorable development of prior-period medical cost reserves, affordability and medical cost management initiatives, and pricing.

Where can I get UnitedHealth Group Incorporated (UNH) financial data in machine-readable form?

Ticker Scout publishes UnitedHealth Group Incorporated's financial statements as JSON at https://tickerscout.ai/unh/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/unh/narrative.md and https://tickerscout.ai/unh/events.md. UnitedHealth Group Incorporated's SEC CIK is 0000731766. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.

When does UnitedHealth Group Incorporated (UNH) next file with the SEC?

UnitedHealth Group Incorporated (UNH) is expected to file its next Form 10-Q with the SEC on or around October 27, 2026. That date is a projection rather than a company-announced date: it is derived from UnitedHealth Group Incorporated's own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q2 FY2026, the period ended 2026-06-30, SEC accession 0000731766-26-000197.

How this page was built

This page was built from UnitedHealth Group Incorporated's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names two such gaps.

A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.

Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer

Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.